Heidelberg Pharma | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Conferences Trial results

8 March 2024

AACR 2024 preview – Lag3, TIGIT and more

BeiGene has a strong presence at this year’s AACR, which features several notable duels.

Trial results

9 February 2024

After Dreamm-7, how about more multiple myeloma conjugates?

boxing blow punch fist glove

Deals

8 November 2023

Genmab deals another blow to CD37

Subscribe to Heidelberg Pharma